| # | Drug | Count |
|---|---|---|
| 0 | EVEROLIMUS | 5 |
| 1 | OCTREOTIDE ACETATE | 5 |
| 2 | METFORMIN | 4 |
| 3 | RAMIPRIL | 4 |
| 4 | RIBOCICLIB | 4 |
| 5 | CAPECITABINE | 3 |
| 6 | CLOPIDOGREL | 3 |
| 7 | CLOPIDOGREL BISULFATE | 3 |
| 8 | EXEMESTANE | 3 |
| 9 | LAMOTIRIGINE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 1 | 0.0021 |
| 1 | ELIGLUSTAT | 1 | 0.0006 |
| 2 | TESTOSTERONE UNDECANOATE | 1 | 0.0005 |
| 3 | LUTETIUM LU 177 DOTATATE | 2 | 0.0003 |
| 4 | BARICITINIB | 1 | 0.0003 |
| 5 | PYRIDOSTIGMINE BROMIDE ORAL | 1 | 0.0003 |
| 6 | APREPITANT | 2 | 0.0003 |
| 7 | LANREOTIDE ACETATE | 2 | 0.0003 |
| 8 | GRANISETRON HYDROCHLORIDE | 2 | 0.0002 |
| 9 | DAROLUTAMIDE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | Somatostatin Analog [EPC] | 3 | 0.0004 |
| 2 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 4 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 5 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 6 | Hepatitis C Virus NS5A Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Aromatase Inhibitor [EPC] | 4 | 0.0000 |
| 9 | Integrin Receptor Antagonist [EPC] | 3 | 0.0000 |